While combination therapy of ACE inhibitor with ARB is not widely used, there is precedent for combination therapy for heart failure (Kuenzli et al., 2010), renal disease (Kunz et al., 2008), and among aged individuals (McAlister et al., 2011). Here, ACE is linked to kidney disorder.